Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9880469dc8f12dad7c3ad95c6ab31fe |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-54 |
filingDate |
2021-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e3f68430b77867ef81f60575d39e6f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97f6244ab3ec7daefb42b464ae514106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59d6be7d3db8dc4491cc6a3c450c7d47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db01cb77df54c2a492bbe304e503765f |
publicationDate |
2022-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2022093971-A1 |
titleOfInvention |
Methods of treating hidradenitis suppurativa |
abstract |
Provided herein are methods for treating a subject suffering from a cutaneous neutrophilic inflammatory disease comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula I or a pharmaceutically acceptable salt thereof, wherein each variable position is as defined herein. In some embodiments, the cutaneous neutrophilic inflammatory disease is Hidradenitis suppurativa (HS). |
priorityDate |
2020-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |